يعرض 1 - 10 نتائج من 41 نتيجة بحث عن '"lower urinary tract infections"', وقت الاستعلام: 1.53s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Meditsinskiy sovet = Medical Council; № 4 (2024); 84-91 ; Медицинский Совет; № 4 (2024); 84-91 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    العلاقة: https://www.med-sovet.pro/jour/article/view/8179/7207Test; González de Llano D, Liu H, Khoo C, Moreno-Arribas MV, Bartolomé B. Some New Findings Regarding the Antiadhesive Activity of Cranberry Phenolic Compounds and Their Microbial-Derived Metabolites against Uropathogenic Bacteria. J Agric Food Chem. 2019;67(8):2166–2174. https://doi.org/10.1021/acs.jafc.8b05625Test.; Sivick KE, Mobley HL. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun. 2010;78(2):568–585. https://doi.org/10.1128/IAI.01000-09Test.; Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB Jr et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57(4):e22–e121. https://doi.org/10.1093/cid/cit278Test.; Hisano M, Bruschini H, Nicodemo AC, Srougi M. Cranberries and lower urinary tract infection prevention. Clinics (Sao Paulo). 2012;67(6):661–668. https://doi.org/10.6061/clinics/2012Test(06)18.; Zhao S, Liu H, Gu L. American cranberries and health benefits – an evolving story of 25 years. J Sci Food Agric. 2020;100(14):5111–5116. https://doi.org/10.1002/jsfa.8882Test.; Occhipinti A, Germano A, Maffei ME. Prevention of Urinary Tract Infection with Oximacro, A Cranberry Extract with a High Content of A-Type Proanthocyanidins: A Pre-Clinical Double-Blind Controlled Study. Urol J. 2016;13(2):2640–2649. https://doi.org/10.22037/uj.v13i2.3190Test.; De Almeida Alvarenga L, Borges NA, Moreira LSG, Resende Teixeira KT, Carraro-Eduardo JC, Dai L et al. Cranberries – potential benefits in patients with chronic kidney disease. Food Funct. 2019;10(6):3103–3112. https://doi.org/10.1039/c9fo00375dTest.; Перепанова ТС, Синякова ЛА, Локшин КЛ. Цистит у женщин: клинические рекомендации. М.; 2021. 35 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/14_2Test.; Коган МИ, Набока ЮЛ, Ибишев ХС, Гудима ИА. Нестерильность мочи здорового человека – новая парадигма в медицине. Урология. 2014;(5):48–52. Режим доступа: https://urologyjournal.ru/archive/article/30323Test.; Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract – a role beyond infection. Nat Rev Urol. 2015;12(2):81–90. https://doi.org/10.1038/nrurol.2014.361Test.; Kline KA, Lewis AL. Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract. Microbiol Spectr. 2016;4(2):10.1128/microbiolspec.UTI-0012-2012. https://doi.org/10.1128/microbiolspec.UTI-0012-2012Test.; Alam Parvez S, Rahman D. Virulence Factors of Uropathogenic E. coli. In: Behzadi P (ed.). Microbiology of Urinary Tract Infections – Microbial Agents and Predisposing Factors. IntechOpen; 2019. https://doi.org/10.5772/intechopen.79557Test.; Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704–712. https://doi.org/10.1001/archinternmed.2012.777Test.; Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. https://doi.org/10.1038/nrmicro3432Test.; González de Llano D, Moreno-Arribas MV, Bartolomé B. Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations. Molecules. 2020;25(15):3523. https://doi.org/10.3390/molecules25153523Test.; Beerepoot M, Geerlings S. Non-Antibiotic Prophylaxis for Urinary Tract Infections. Pathogens. 2016;5(2):36. https://doi.org/10.3390/pathogens5020036Test.; Jagannathan V, Viswanathan P. Proanthocyanidins – will they effectively restrain conspicuous bacterial strains devolving on urinary tract infection? J Basic Microbiol. 2018;58(7):567–578. https://doi.org/10.1002/jobm.201800131Test.; Foo LY, Lu Y, Howell AB, Vorsa N. A-Type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Nat Prod. 2000;63(9):1225–1228. https://doi.org/10.1021/np000128uTest.; Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapleton AE. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol. 2007;177(6):2357–2360. https://doi.org/10.1016/j.juro.2007.01.114Test.; Di Martino P, Agniel R, David K, Templer C, Gaillard JL, Denys P, Botto H. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebocontrolled cross-over trial. World J Urol. 2006;24(1):21–27. https://doi.org/10.1007/s00345-005-0045-zTest.; Howell AB. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Mol Nutr Food Res. 2007;51(6):732–737. https://doi.org/10.1002/mnfr.200700038Test.; Howell AB, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA. 2002;287(23):3082–3083. https://doi.org/10.1001/jama.287.23.3082Test.; Bononi M, Tateo F. Stabilization of cranberry anthocyanins in nutraceutical capsules. Int J Food Sci Nutr. 2007;58(2):142–149. https://doi.org/10.1080/09637480601154061Test.; Williams G, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023;4(4):CD001321. https://doi.org/10.1002/14651858.CD001321.pub6Test.; Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol. 2015;213(2):194.e1–8. https://doi.org/10.1016/j.ajog.2015.04.003Test.; Scharf B, Schmidt TJ, Rabbani S, Stork C, Dobrindt U, Sendker J et al. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract? J Ethnopharmacol. 2020;257:112889. https://doi.org/10.1016/j.jep.2020.112889Test.; Scharf B, Sendker J, Dobrindt U, Hensel A. Influence of Cranberry Extract on Tamm-Horsfall Protein in Human Urine and its Antiadhesive Activity Against Uropathogenic Escherichia coli. Planta Med. 2019;85(2):126–138. https://doi.org/10.1055/a-0755-7801Test.; Кульчавеня ЕВ, Трейвиш ЛС, Телина ЕВ. Альтернативные виды терапии рецидивирующего цистита у женщин в менопаузе. Медицинский совет. 2022;(14):164–170. https://doi.org/10.21518/2079-701X-2022-16-14-164-170Test.; Sharon N. Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta. 2006;1760(4):527–537. https://doi.org/10.1016/j.bbagen.2005.12.008Test.; Feenstra T, Thøgersen MS, Wieser E, Peschel A, Ball MJ, Brandes R et al. Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations. Eur J Clin Microbiol Infect Dis. 2017;36(3):467–478. https://doi.org/10.1007/s10096-016-2820-8Test.; Lenger SM, Bradley MS, Thomas DA, Bertolet MH, Lowder JL, Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13. https://doi.org/10.1016/j.ajog.2020.05.048Test.; Konesan J, Wang J, Moore KH, Mansfield KJ, Liu L. Cranberry, but not D-mannose and ibuprofen, prevents against uropathogenic Escherichia coli-induced cell damage and cell death in MDCK cells. Front Microbiol. 2023;14:1319785. https://doi.org/10.3389/fmicb.2023.1319785Test.; Нашивочникова НА, Леанович ВЕ. Опыт применения растительных препаратов в комплексном лечении неосложненных инфекций нижних мочевыводящих путей у беременных. Урология. 2020;(5):33–36. https://doi.org/10.18565/urology.2020.5.33-36Test.; Нашивочникова НА, Крупин ВН. Профилактика рецидивов острого цистита. РМЖ. 2017;(8):503–505. Режим доступа: https://www.rmj.ru/articles/urologiya/Profilaktika_recidivov_ostrogo_cistitaTest/.; Нашивочникова НА, Крупин ВН, Леанович ВЕ. Особенности профилактики и лечения неосложненных инфекций нижних мочевыводящих путей у беременных. РМЖ. Мать и дитя. 2021;4(2):119–123. https://doi.org/10.32364/2618-8430-2021-4-2-119-123Test.; Кравченко ЕН, Куклина ЛВ. Бессимптомная бактериурия беременных: оценка эффективности лечения. Женская клиника. 2022;(2):43–48. Режим доступа: https://elibrary.ru/rddiuuTest.; Нашивочникова НА, Леанович ВЕ. Клинико-патогенетические аспекты лечения и профилактики пиелонефрита у детей. Урология. 2022;(6):97–104. https://doi.org/10.18565/urology.2022.6.97-104Test.; Котов СВ, Перов РА. Комбинированная профилактика рецидивирующих воспалительных заболеваний нижних мочевыводящих путей у детей и беременных. Урология. 2020;(2):122–126. https://doi.org/10.18565/urology.2020.2.122-126Test.; Кульчавеня ЕВ. Контроль внелегочного туберкулеза в Сибири и на Дальнем Востоке. Проблемы туберкулеза и болезней легких. 2008;85(9):16–19. Режим доступа: https://elibrary.ru/mwdfllTest.; Kulchavenya E, Kholtobin D, Shevchenko S. Challenges in urogenital tuberculosis. World J Urol. 2020;38(1):89–94. https://doi.org/10.1007/s00345-019-02767-xTest.; https://www.med-sovet.pro/jour/article/view/8179Test

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10